Eptifibatide | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Eptifibatide
Health Canada Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Eptifibatide

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

26 API Suppliers, 15 USDMF, 6 NDC API, 14 Listed Suppliers, $ API Reference Price

26 API Suppliers
15 USDMF
6 NDC API
14 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

FINISHED DOSAGE FORMULATIONS

54 FDF Dossiers, 29 FDA Orange Book, 12 Europe, 2 Canada, 2 South Africa, 9 Listed Dossiers

54 FDF Dossiers
29 FDA Orange Book
12 Europe
2 Canada
2 South Africa
9 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 2MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 75MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 2MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
INJECTABLE;INJECTION - 75MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

DIGITAL CONTENT

15 NEWS #PharmaBuzz

15 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

6 Finished Drug Prices

6 Finished Drug Prices

MARKET PLACE

8 APIs

8 APIs

PATENTS & EXCLUSIVITIES

6 Health Canada Patents

6 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 Others

3 Others

$ API Ref.Price (USD/KG) : 211,602 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

6 All

01 4Merck Canada Inc.

02 2Blank

filter Patent Reset all filters

6 All

01 22059124

02 22133205

03 22573307

filter Product Reset all filters

6 All

01 4Eptifibatide

02 2Blank

filter Dosage Reset all filters

6 All

01 4Solution for Injection

02 2Blank

filter Exp Date Reset all filters

6 All

01 22010-06-15

02 42013-04-27

Product Main Page

01

Merck Canada Inc.

Eptifibatide

PharmScience R&D

Not Confirmed

Merck Canada Inc.

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2013-04-27

Date Granted : 2007-04-17

Eptifibatide

Brand Name : INTEGRILIN

Patent Number : 2133205

Filing Date : 1993-04-27

Strength per Unit : 0.75 mg / mL

Dosage Form : Solution for Injection

Human Or VET : Human

Route of Administration : Intravenous

Patent Expiration Date : 2013-04-27

Date Granted : 2007-04-17

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Merck Canada Inc.

Eptifibatide

PharmScience R&D

Not Confirmed

Merck Canada Inc.

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2013-04-27

Date Granted : 2011-01-04

Eptifibatide

Brand Name : INTEGRILIN

Patent Number : 2573307

Filing Date : 1993-04-27

Strength per Unit : 0.75 mg / mL

Dosage Form : Solution for Injection

Human Or VET : Human

Route of Administration : Intravenous

Patent Expiration Date : 2013-04-27

Date Granted : 2011-01-04

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Merck Canada Inc.

Eptifibatide

PharmScience R&D

Not Confirmed

Merck Canada Inc.

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2013-04-27

Date Granted : 2007-04-17

Eptifibatide

Brand Name : INTEGRILIN

Patent Number : 2133205

Filing Date : 1993-04-27

Strength per Unit : 2.0 mg / mL

Dosage Form : Solution for Injection

Human Or VET : Human

Route of Administration : Intravenous

Patent Expiration Date : 2013-04-27

Date Granted : 2007-04-17

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Merck Canada Inc.

Eptifibatide

PharmScience R&D

Not Confirmed

Merck Canada Inc.

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2013-04-27

Date Granted : 2011-01-04

Eptifibatide

Brand Name : INTEGRILIN

Patent Number : 2573307

Filing Date : 1993-04-27

Strength per Unit : 2.0 mg / mL

Dosage Form : Solution for Injection

Human Or VET : Human

Route of Administration : Intravenous

Patent Expiration Date : 2013-04-27

Date Granted : 2011-01-04

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Eptifibatide

PharmScience R&D

Not Confirmed

Country

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2010-06-15

Date Granted :

Eptifibatide

Brand Name :

Patent Number : 2059124

Filing Date :

Strength per Unit :

Dosage Form :

Human Or VET :

Route of Administration :

Patent Expiration Date : 2010-06-15

Date Granted :

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

06

Eptifibatide

PharmScience R&D

Not Confirmed

Country

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2010-06-15

Date Granted :

Eptifibatide

Brand Name :

Patent Number : 2059124

Filing Date :

Strength per Unit :

Dosage Form :

Human Or VET :

Route of Administration :

Patent Expiration Date : 2010-06-15

Date Granted :

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!